Sale!

SLC2A1 Gene Epilepsy idiopathic generalized type 12 Genetic Test

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The SLC2A1 Gene Epilepsy idiopathic generalized type 12 Genetic Test is a specialized diagnostic procedure offered by DNA Labs UAE, designed to identify mutations in the SLC2A1 gene, which are associated with Epilepsy, idiopathic generalized type 12. This type of epilepsy is a genetic disorder characterized by seizures with no apparent cause, and it has been linked to variations in the SLC2A1 gene. The test plays a crucial role in the early detection and management of the condition, enabling healthcare providers to tailor treatment plans based on the genetic makeup of the individual.

Priced at 4400 AED, the test is conducted using a sample of the patient’s DNA, typically extracted from a blood sample. The process involves advanced genetic sequencing techniques to meticulously analyze the SLC2A1 gene for specific mutations known to contribute to the development of epilepsy. The results from this test can provide valuable insights into the patient’s condition, including the likelihood of developing epilepsy, potential response to treatments, and the risk of passing the condition on to future generations.

DNA Labs UAE is known for its state-of-the-art facilities and expertise in genetic testing, offering accurate and reliable results. The test is recommended for individuals with a family history of epilepsy or those who exhibit symptoms associated with the disorder, aiming to provide them with a clearer understanding of their condition and how best to manage it.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

SLC2A1 Gene Epilepsy Idiopathic Generalized Type 12 Genetic Test

At DNA Labs UAE, we offer the SLC2A1 Gene Epilepsy idiopathic generalized type 12 Genetic Test for individuals who suspect they may have this condition. This test can provide valuable insights into your genetic makeup and help guide treatment decisions.

Test Components

The SLC2A1 Gene Epilepsy idiopathic generalized type 12 Genetic Test includes the following components:

  • Price: 4400.0 AED
  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
  • Report Delivery: 3 to 4 Weeks
  • Method: NGS Technology
  • Test Type: Neurological Disorders
  • Doctor: Neurologist
  • Test Department: Genetics

Pre Test Information

Before undergoing the SLC2A1 Gene Epilepsy idiopathic generalized type 12 Genetic Test, it is recommended to provide the following:

  • Clinical History of Patient who is going for SLC2A1 Gene Epilepsy, idiopathic generalized type 12 NGS Genetic DNA Test
  • A Genetic Counselling session to draw a pedigree chart of family members affected with SLC2A1 Gene Epilepsy, idiopathic generalized type 12

Test Details

The SLC2A1 gene is responsible for encoding a glucose transporter protein called GLUT1. This protein plays a crucial role in transporting glucose across the blood-brain barrier and into brain cells. Mutations in the SLC2A1 gene have been linked to a rare form of epilepsy known as idiopathic generalized epilepsy type 12 (IGE12).

Individuals with IGE12 typically experience generalized seizures that start in childhood or adolescence and are challenging to control with medication. To confirm a diagnosis of IGE12, NGS genetic testing for SLC2A1 mutations can be conducted. This test involves sequencing the entire SLC2A1 gene to identify any mutations or variations that may contribute to the individual’s symptoms.

By undergoing this type of genetic testing, a more accurate diagnosis can be obtained, leading to better treatment decisions. Treatment options for individuals with a mutation in the SLC2A1 gene may include a ketogenic diet, which is high in fat and low in carbohydrates. This diet has been shown to improve seizure control in individuals with GLUT1 deficiency syndrome, a related condition caused by mutations in the SLC2A1 gene. Other treatment options may involve anticonvulsant medications and/or surgery to remove the affected area of the brain.

At DNA Labs UAE, we are committed to providing accurate and reliable genetic testing services. Our SLC2A1 Gene Epilepsy idiopathic generalized type 12 Genetic Test can help individuals understand their condition better and make informed decisions regarding their treatment.

Test Name SLC2A1 Gene Epilepsy idiopathic generalized type 12 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for SLC2A1 Gene Epilepsy, idiopathic generalized type 12 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with SLC2A1 Gene Epilepsy, idiopathic generalized type 12
Test Details

The SLC2A1 gene encodes for a glucose transporter protein known as GLUT1, which is responsible for transporting glucose across the blood-brain barrier and into brain cells. Mutations in the SLC2A1 gene have been associated with a rare form of epilepsy called idiopathic generalized epilepsy type 12 (IGE12).

NGS genetic testing for SLC2A1 mutations can be used to confirm a diagnosis of IGE12 in individuals with symptoms of the condition. Symptoms of IGE12 typically include generalized seizures that begin in childhood or adolescence and are difficult to control with medication.

NGS genetic testing involves sequencing the entire SLC2A1 gene to identify any mutations or variations that may be contributing to the individual’s symptoms. This type of testing can provide a more accurate diagnosis and help guide treatment decisions.

If a mutation in the SLC2A1 gene is identified, treatment may involve a ketogenic diet, which is high in fat and low in carbohydrates, and has been shown to improve seizure control in individuals with GLUT1 deficiency syndrome (a related condition caused by mutations in the SLC2A1 gene). Other treatments may include anticonvulsant medications and/or surgery to remove the affected area of the brain.